Unpacking Impax Small Cap Fund's Q1 2026 Journey: Performance, Strategy, and What Lies Ahead

Well, another quarter has certainly flown by, hasn't it? As we wrap up the first quarter of 2026, it’s a moment to pause, reflect, and frankly, share our thoughts on the Impax Small Cap Fund's performance and the broader market landscape. It's always fascinating to see how the market behaves, particularly in the often-volatile small-cap segment, and Q1 certainly gave us plenty to talk about.

Looking back at the economic backdrop for the first three months of the year, we saw a continuation of several trends, alongside some intriguing new developments. Inflation, while showing signs of cooling in some areas, remained a persistent talking point, influencing consumer behavior and, naturally, corporate bottom lines. Interest rate speculation, as you might expect, continued to be a significant driver of sentiment, with investors trying to second-guess central bank moves. What's more interesting, though, is how resilient certain pockets of the economy proved to be, even in the face of these broader macro pressures.

So, how did our Impax Small Cap Fund fare amidst all this? I'm pleased to report that the fund delivered a solid performance during Q1 2026. While the small-cap universe, as a whole, experienced its usual ups and downs, our thoughtful, fundamentally driven approach really helped us navigate these choppy waters. We saw some benchmarks delivering modest gains, and we were quite satisfied with how our specific selections contributed to our overall results, often outperforming the broader indices.

Breaking down the numbers, some stars really shone bright this quarter. Our overweight positions in companies benefiting from secular growth trends, particularly within sustainable technology and healthcare innovation, proved to be significant positive contributors. For instance, a few of our holdings in advanced materials, crucial for the ongoing energy transition, demonstrated impressive earnings growth and market traction. Likewise, certain specialized medical device firms, which we believe offer genuinely disruptive solutions, saw their valuations climb as investor confidence in their long-term potential solidified. It's truly rewarding to see our investment thesis play out so clearly in these areas.

Of course, it wasn't all smooth sailing. Every quarter presents its own set of challenges, and Q1 2026 was no exception. We did encounter some headwinds with a couple of our holdings in more traditional industrial sectors, where rising input costs or unexpected supply chain kinks put a damper on their short-term performance. While these were minor detractors from the overall fund's positive showing, we've naturally engaged deeply with management teams and re-evaluated our positions, always looking for that fundamental strength that aligns with our long-term vision. Sometimes, patience is truly a virtue in investing, you know?

This quarter, like many others, really underscored the robustness of our core investment philosophy. We remain firmly committed to identifying high-quality, sustainable small-cap businesses that are leaders in their respective niches and are poised for long-term growth. Our rigorous due diligence, combined with an eye towards environmental, social, and governance (ESG) factors, continues to be the bedrock of our decision-making. We're not just chasing fads; we're investing in the future, plain and simple.

Peering into the crystal ball, or at least our well-researched models, what do we see for the remainder of 2026? The small-cap landscape continues to present a fascinating mix of opportunities and potential challenges. We anticipate ongoing discussions around interest rates and their impact on borrowing costs, which could certainly affect some businesses more than others. However, we also see tremendous potential in companies innovating around resource efficiency, digitalization, and healthy living – themes that are becoming increasingly central to the global economy. We believe our portfolio is exceptionally well-positioned to capitalize on these enduring shifts.

Ultimately, as we move deeper into 2026, our conviction remains strong. The Impax Small Cap Fund is built on a foundation of thorough research, a long-term perspective, and an unwavering commitment to sustainable investing principles. We're genuinely excited about the opportunities ahead and remain dedicated to seeking out those exceptional small businesses that can truly make a difference, both for our investors and for a more sustainable world. Thank you, as always, for your trust and continued support.